EVGN icon

Evogene

17 hedge funds and large institutions have $15.2M invested in Evogene in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
WRF
1
Waddell & Reed Financial
Kansas
$4.42M 2,795,703
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$3.68M 221,311
UBS Group
3
UBS Group
Switzerland
$2.23M 1,412,326 -34,596 -2%
Goldman Sachs
4
Goldman Sachs
New York
$1.21M 767,184
CI
5
Clal Insurance
Israel
$934K 591,264
SM
6
Senvest Management
New York
$655K 414,682
MCM
7
Moon Capital Management
New York
$578K 365,738
Bank of America
8
Bank of America
North Carolina
$514K 325,104
PF
9
Phoenix Financial
Israel
$397K 263,133 +263,133 New
AIM
10
ARK Investment Management
Florida
$331K 209,248 +6,258 +3%
MIH
11
Meitav Investment House
Israel
$121K 71,851 +18,110 +34%
Jane Street
12
Jane Street
New York
$56K 35,743 +6,899 +24%
Citadel Advisors
13
Citadel Advisors
Florida
$31K 19,375 +19,375 New
Morgan Stanley
14
Morgan Stanley
New York
$16K 10,052 -10,000 -50%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$16K 10,000
Citigroup
16
Citigroup
New York
$13K 7,976
Barclays
17
Barclays
United Kingdom
$1K 696 -290 -29%
EVC
18
Eidelman Virant Capital
Missouri
-63,600 Closed
Norges Bank
19
Norges Bank
Norway
-232 Closed
CFGS
20
Concourse Financial Group Securities
Alabama